Canfield News

Dr. Allan Halpern of Memorial Sloan Kettering Cancer Center discusses VECTRA® WB360 technology on CBS News

CBS News interviewed Dr. Allan Halpern, Chief of Dermatology at Memorial Sloan Kettering Cancer Center, about the VECTRA WB360’s advanced imaging technology and its role assisting doctors in detecting signs of melanoma. Dr. Halpern demonstrated how the system captures cross-polarized and non-polarized images using 92 cameras firing simultaneously, providing an accurate 3D representation of the patient’s skin. The VECTRA WB360 provides clinicians like Dr. Halpern a powerful tool to screen patients thoroughly, especially important now since so many have missed their normal appointments in the past year due to the pandemic. The Journal of American Academy of Dermatology reported as many as 19,600 melanomas may not have been diagnosed or treated in 2020. Dr. Halpern explained that he is leveraging technology like the WB360 to “help do a better job, to catch melanoma at the earliest possible stage while at the same time avoiding a lot of unnecessary biopsies.”